Ginkgo Automation Welcomes Brian O'Sullivan to Lead Commercial Expansion Efforts Globally

Ginkgo Automation's New Chapter Under Brian O'Sullivan

In a strategic move to bolster its commercial endeavors, Ginkgo Bioworks (NYSE: DNA), renowned for its innovative platform in cell programming and biosecurity, announced the appointment of Brian O'Sullivan as the Head of Commercial for Ginkgo Automation as of August 12, 2025. This appointment is pivotal, especially as Ginkgo Automation aims to broaden its reach within the biopharmaceutical and technology sectors, capitalizing on newly emerging science-driven markets.

Brian O'Sullivan, a seasoned executive with extensive experience in the life sciences sector, comes to Ginkgo from HighRes Biosolutions, where he was instrumental in driving their commercial initiatives. He will be responsible for overseeing all revenue-generating activities within Ginkgo Automation, which includes sales, business development, marketing, channel partnerships, and customer success. This role comes at a crucial time since Ginkgo Automation has transitioned from focusing solely on Ginkgo's internal R&D initiatives to offering its advanced modular Reconfigurable Automation Cart (RAC) hardware and Catalyst automation software to external clients.

The last year has seen Ginkgo Automation rapidly expand its clientele, which now includes organizations in biopharma, diagnostics, and national laboratories. “Brian has consistently built top-performing commercial teams that translate advanced technology into clear customer value,” stated Will Serber, General Manager of Ginkgo Automation. His experience in executing large automation transactions and his strong connections within the life sciences market are expected to significantly contribute to Ginkgo's global scaling efforts.

During his tenure at HighRes, O'Sullivan successfully built the commercial organization from scratch, which led to a dramatic increase in annual bookings. He was key in establishing strategic partnerships across prominent segments of the industry and played a pivotal role in the company’s expansion into European and Asia Pacific markets. His previous experience also includes senior positions at Agilent Technologies, Velocity11, and Beckman Coulter, where he pushed for growth in small molecule and biologic applications. O'Sullivan received his Bachelor of Science in Biochemistry from California Polytechnic State University, San Luis Obispo.

In his remarks about joining Ginkgo, O'Sullivan expressed enthusiasm about the company’s innovative approach: “Ginkgo Automation pairs best-in-class hardware with an AI-ready software stack that integrates experiment design with data generation—precisely what scientists require to expedite discovery. I’m excited to collaborate with this talented team to empower our customers to redefine what is attainable in their laboratories.”

Brian will be based in Emeryville, California, and will report directly to Will Serber. His immediate objectives include enhancing Ginkgo Automation’s commercial outreach, nurturing relationships with key enterprise clients, and accelerating the adoption of its sophisticated solutions across various segments.

Ginkgo Automation’s capabilities are now available on-site, inviting potential clients to explore their RACs and Catalyst software solutions. For more information, visit their official site or follow their developments on various social media platforms such as Twitter, Instagram, and LinkedIn.

About Ginkgo Bioworks

Ginkgo Bioworks specializes in creating tools to simplify biological engineering. Their R&D solutions offer customizable packages to expedite innovation in therapeutics, diagnostics, and manufacturing processes. The company’s Automation division provides integrated lab solutions enabling scientists to focus on experiment design and analysis rather than routine lab tasks. Furthermore, Ginkgo Datapoints utilizes in-house automation to assemble substantial data sets vital for AI model training, while its Biosecurity division works towards developing infrastructures to address biological threats effectively.

In summary, with Brian O'Sullivan at the helm of commercial strategy, Ginkgo Automation is well-positioned to enhance its market footprint and redefine industry standards for laboratory automation technologies.